List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Japanese Encephalitis - Overview
Japanese Encephalitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Japanese Encephalitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Japanese Encephalitis - Companies Involved in Therapeutics Development
Abivax SA
Adimmune Corp
BioNet-Asia Co Ltd
Cadila Healthcare Ltd
Ennaid Therapeutics LLC
Fab'entech SA
Medigen Inc
Sinovac Biotech Ltd
Japanese Encephalitis - Drug Profiles
ABX-196 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FDX-000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibodies for Japanese Encephalitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit NS5 for Japanese Encephalitis and Viral Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides for Japanese Encephalitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Flavivirus Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese Encephalitis - Dormant Projects
Japanese Encephalitis - Discontinued Products
Japanese Encephalitis - Product Development Milestones
Featured News & Press Releases
Aug 19, 2020: New Chinese viral encephalitis vaccine shows dual protection
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Japanese Encephalitis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Japanese Encephalitis - Pipeline by Abivax SA, 2021
Japanese Encephalitis - Pipeline by Adimmune Corp, 2021
Japanese Encephalitis - Pipeline by BioNet-Asia Co Ltd, 2021
Japanese Encephalitis - Pipeline by Cadila Healthcare Ltd, 2021
Japanese Encephalitis - Pipeline by Ennaid Therapeutics LLC, 2021
Japanese Encephalitis - Pipeline by Fab'entech SA, 2021
Japanese Encephalitis - Pipeline by Medigen Inc, 2021
Japanese Encephalitis - Pipeline by Sinovac Biotech Ltd, 2021
Japanese Encephalitis - Dormant Projects, 2021
Japanese Encephalitis - Discontinued Products, 2021

List of Figures
Number of Products under Development for Japanese Encephalitis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Abivax SA
• Adimmune Corp
• BioNet-Asia Co Ltd
• Cadila Healthcare Ltd
• Ennaid Therapeutics LLC
• Fab'entech SA
• Medigen Inc
• Sinovac Biotech Ltd